Assessment of intermediate-term mortality following pancreatectomy for cancer
Nearly 10% of patients undergoing pancreatectomy for cancer died within 6 months, of which one-half occurred in the intermediate term. These data have real-world implications to improve shared decision making when discussing curative-intent pancreatectomy.
Authors
- Ted A. Skolarus (ORCID: https://orcid.org/0000-0002-5859-8151)
- Ryan P. Merkow (ORCID: https://orcid.org/0000-0002-8752-4653)
- Karl Y. Bilimoria (ORCID: https://orcid.org/0000-0001-5067-1345)
- David D. Odell (ORCID: https://orcid.org/0000-0002-0121-4831)
- Elizabeth C. Danielson (ORCID: https://orcid.org/0000-0003-2792-7140)
- Michael Visenio
- Mitchell C. Posner (ORCID: https://orcid.org/0009-0004-6495-1961)
- Rachel Hae‐Soo Joung (ORCID: https://orcid.org/0000-0002-4120-1058)
- David J. Bentrem (ORCID: https://orcid.org/0000-0003-0131-9323)
- Anthony D. Yang (ORCID: https://orcid.org/0000-0002-9053-0974)
- Lauren M. Janczewski (ORCID: https://orcid.org/0000-0003-2721-3519)
Institutions
- Northwestern University (US)
- University of Michigan (US)
- University of Chicago (US)
- Michigan Medicine (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1093/jnci/djae215
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute